Clearbridge Cut By $3.43 Million Its Biogen (BIIB) Stake; Shorts at CYBERFORT SOFTWARE (CYBF) Raised By 680%

March 20, 2018 - By Stephen Andrade

CYBERFORT SOFTWARE INC (OTCMKTS:CYBF) had an increase of 680% in short interest. CYBF’s SI was 3,900 shares in March as released by FINRA. Its up 680% from 500 shares previously. The SI to CYBERFORT SOFTWARE INC’s float is 0.01%. It closed at $0.002 lastly. It is down 0.00% since March 20, 2017 and is . It has underperformed by 16.70% the S&P500.

Clearbridge Llc decreased Biogen Inc (BIIB) stake by 4.85% reported in 2017Q3 SEC filing. Clearbridge Llc sold 10,950 shares as Biogen Inc (BIIB)’s stock declined 13.45%. The Clearbridge Llc holds 214,690 shares with $67.22 million value, down from 225,640 last quarter. Biogen Inc now has $59.17 billion valuation. The stock increased 0.47% or $1.31 during the last trading session, reaching $279.68. About 1.12 million shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since March 20, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Cyberfort Software, Inc., a cyber security technology company, engages in the acquisition and development of security software, content filtering, and ad-blocking technology worldwide. The company has market cap of $171,519. It intends to deal with the various cyber threats through protection technologies for mobile, personal, and business tech devices across various platforms. It currently has negative earnings. The firm provides Vivio, an iOS 10 ad-blocking app that allows the user to experience the Web the way it is supposed to be, faster and cleaner, without compromising their online safety.

Since January 9, 2018, it had 0 insider purchases, and 5 insider sales for $2.87 million activity. 743 shares valued at $216,956 were sold by Sandrock Alfred on Tuesday, February 20. PANGIA ROBERT W sold $1.92M worth of stock.

Among 33 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 24 have Buy rating, 0 Sell and 9 Hold. Therefore 73% are positive. Biogen Idec Inc. had 117 analyst reports since July 23, 2015 according to SRatingsIntel. The stock has “Buy” rating by Mizuho on Tuesday, November 8. The firm earned “Buy” rating on Thursday, October 22 by H.C. Wainwright. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Neutral” rating by Robert W. Baird on Friday, March 11. Raymond James maintained Biogen Inc. (NASDAQ:BIIB) on Tuesday, August 2 with “Strong Buy” rating. The rating was maintained by Cowen & Co with “Buy” on Thursday, January 25. The rating was maintained by Stifel Nicolaus on Monday, October 23 with “Buy”. Leerink Swann upgraded the shares of BIIB in report on Monday, November 7 to “Outperform” rating. The firm earned “Buy” rating on Monday, October 23 by Guggenheim. Stifel Nicolaus maintained Biogen Inc. (NASDAQ:BIIB) on Friday, December 9 with “Hold” rating. The stock has “Hold” rating by Jefferies on Thursday, January 25.

Investors sentiment increased to 1.17 in 2017 Q3. Its up 0.04, from 1.13 in 2017Q2. It increased, as 59 investors sold BIIB shares while 283 reduced holdings. 96 funds opened positions while 292 raised stakes. 181.16 million shares or 0.28% more from 180.66 million shares in 2017Q2 were reported. Duncker Streett & Com invested 0% of its portfolio in Biogen Inc. (NASDAQ:BIIB). 6,738 were reported by Eqis Mgmt. Massachusetts Financial Service Ma has 0.24% invested in Biogen Inc. (NASDAQ:BIIB) for 1.79 million shares. Deroy And Devereaux Private Investment Counsel owns 1,000 shares or 0.04% of their US portfolio. Wetherby Asset reported 3,306 shares stake. Mitsubishi Ufj Trust And Banking Corporation invested 0.26% in Biogen Inc. (NASDAQ:BIIB). Stevens Mgmt Lp stated it has 0.16% in Biogen Inc. (NASDAQ:BIIB). Winfield Assoc Inc has invested 0.05% in Biogen Inc. (NASDAQ:BIIB). Grandfield & Dodd Ltd Company owns 1,147 shares. M&T National Bank invested 0.13% in Biogen Inc. (NASDAQ:BIIB). Bank Of Nova Scotia stated it has 0.07% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Vident Invest Advisory Ltd Liability Corporation holds 0.02% or 985 shares. Rosenbaum Jay D owns 2,104 shares. Bamco Inc invested 0.02% in Biogen Inc. (NASDAQ:BIIB). Ballentine Ptnrs Ltd Liability Corp stated it has 0.03% of its portfolio in Biogen Inc. (NASDAQ:BIIB).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: